These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25605650)

  • 61. Analysis of biomarker serum levels in IVIG and infliximab refractory Kawasaki disease patients.
    Hachiya A; Kobayashi N; Matsuzaki S; Takeuchi Y; Akazawa Y; Shigemura T; Motoki N; Masumoto J; Agematsu K
    Clin Rheumatol; 2018 Jul; 37(7):1937-1943. PubMed ID: 29302828
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Observational study of Interleukin-21 (IL-21) does not distinguish Kawasaki disease from other causes of fever in children.
    Engelberg R; Martin M; Wrotniak BH; Hicar MD
    Pediatr Rheumatol Online J; 2017 Apr; 15(1):32. PubMed ID: 28427414
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression Signature.
    Wright VJ; Herberg JA; Kaforou M; Shimizu C; Eleftherohorinou H; Shailes H; Barendregt AM; Menikou S; Gormley S; Berk M; Hoang LT; Tremoulet AH; Kanegaye JT; Coin LJM; Glodé MP; Hibberd M; Kuijpers TW; Hoggart CJ; Burns JC; Levin M;
    JAMA Pediatr; 2018 Oct; 172(10):e182293. PubMed ID: 30083721
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Circulating microRNAs differentiate Kawasaki Disease from infectious febrile illnesses in childhood.
    Jone PN; Korst A; Karimpour-Fard A; Thomas T; Dominguez SR; Heizer H; Anderson MS; Glode MP; Sucharov CC; Miyamoto SD
    J Mol Cell Cardiol; 2020 Sep; 146():12-18. PubMed ID: 32634388
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serum miR-92a-3p as a New Potential Biomarker for Diagnosis of Kawasaki Disease with Coronary Artery Lesions.
    Rong X; Jia L; Hong L; Pan L; Xue X; Zhang C; Lu J; Jin Z; Qiu H; Wu R; Chu M
    J Cardiovasc Transl Res; 2017 Feb; 10(1):1-8. PubMed ID: 27981487
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease.
    Giordani L; Quaranta MG; Marchesi A; Straface E; Pietraforte D; Villani A; Malorni W; Del Principe D; Viora M
    Clin Exp Immunol; 2011 Mar; 163(3):346-53. PubMed ID: 21175593
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Coronary artery dimensions in febrile children without Kawasaki disease.
    Muniz JC; Dummer K; Gauvreau K; Colan SD; Fulton DR; Newburger JW
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):239-44. PubMed ID: 23357243
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The differential equation model of pathogenesis of Kawasaki disease with theoretical analysis.
    Qiang R; Ma W; Guo K; Du H
    Math Biosci Eng; 2019 Apr; 16(5):3488-3511. PubMed ID: 31499625
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Markedly elevated CD64 expression on neutrophils and monocytes as a biomarker for diagnosis and therapy assessment in Kawasaki disease.
    Hokibara S; Kobayashi N; Kobayashi K; Shigemura T; Nagumo H; Takizawa M; Yamazaki T; Agematsu K
    Inflamm Res; 2016 Jul; 65(7):579-85. PubMed ID: 27020279
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Elevated Inducible Nitric Oxide Levels and Decreased Hydrogen Sulfide Levels Can Predict the Risk of Coronary Artery Ectasia in Kawasaki Disease.
    Song R; Liu G; Li X; Xu W; Liu J; Jin H
    Pediatr Cardiol; 2016 Feb; 37(2):322-9. PubMed ID: 26499359
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Increased plasma endothelin levels in Kawasaki disease: a possible marker for Kawasaki disease.
    Morise T; Takeuchi Y; Takeda R; Karayalcin U; Yachie A; Miyawaki T
    Angiology; 1993 Sep; 44(9):719-23. PubMed ID: 8357099
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increase expression of CD177 in Kawasaki disease.
    Huang YH; Lo MH; Cai XY; Liu SF; Kuo HC
    Pediatr Rheumatol Online J; 2019 Apr; 17(1):13. PubMed ID: 30943984
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Axillary, Oral and Rectal Routes of Temperature Measurement During Treatment of Acute Kawasaki Disease.
    Kanegaye JT; Jones JM; Burns JC; Jain S; Sun X; Jimenez-Fernandez S; Berry E; Pancheri JM; Jaggi P; Ramilo O; Tremoulet AH
    Pediatr Infect Dis J; 2016 Jan; 35(1):50-3. PubMed ID: 26398742
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inflammatory processes in Kawasaki disease reach their peak at the sixth day of fever onset: laboratory profiles according to duration of fever.
    Lee KY; Han JW; Hong JH; Lee HS; Lee JS; Whang KT
    J Korean Med Sci; 2004 Aug; 19(4):501-4. PubMed ID: 15308837
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Downregulation of Th17 cells and the related cytokines with treatment in Kawasaki disease.
    Rasouli M; Heidari B; Kalani M
    Immunol Lett; 2014 Nov; 162(1 Pt A):269-75. PubMed ID: 25277751
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease.
    Furukawa S; Imai K; Matsubara T; Yone K; Yachi A; Okumura K; Yabuta K
    Arthritis Rheum; 1992 Jun; 35(6):672-7. PubMed ID: 1350908
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Elevation of IL-17 Cytokines Distinguishes Kawasaki Disease From Other Pediatric Inflammatory Disorders.
    Brodeur KE; Liu M; Ibanez D; de Groot MJ; Chen L; Du Y; Seyal E; Laza-Briviesca R; Baker A; Chang JC; Chang MH; Day-Lewis M; Dedeoglu F; Dionne A; de Ferranti SD; Friedman KG; Halyabar O; Lo MS; Meidan E; Sundel RP; Henderson LA; Nigrovic PA; Newburger JW; Son MB; Lee PY
    Arthritis Rheumatol; 2024 Feb; 76(2):285-292. PubMed ID: 37610270
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cytokine profile of macrophage activation syndrome associated with Kawasaki disease.
    Jinkawa A; Shimizu M; Nishida K; Kaneko S; Usami M; Sakumura N; Irabu H; Takakuwa M; Inoue N; Mizuta M; Ikawa Y; Fujita S; Yachie A
    Cytokine; 2019 Jul; 119():52-56. PubMed ID: 30877950
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The expression and significance of serum caveolin-1 in patients with Kawasaki disease.
    Zhu F; Huang J; Wang X; Li P; Yan Y; Zheng Y; He Y; Wu T; Ren Y; Wu R
    Chin J Physiol; 2020; 63(2):90-94. PubMed ID: 32341235
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Changes in and significance of platelet function and parameters in Kawasaki disease.
    Zheng X; Wu W; Zhang Y; Wu G
    Sci Rep; 2019 Nov; 9(1):17641. PubMed ID: 31776411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.